Patents by Inventor Peter Callas

Peter Callas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11931096
    Abstract: System for electrically ablating tissue of a patient through a plurality of electrodes includes a memory, a processor and a treatment control module stored in the memory and executable by the processor. The treatment control module generates an estimated treatment region based on the number of electrical pulses to be applied.
    Type: Grant
    Filed: June 14, 2021
    Date of Patent: March 19, 2024
    Assignee: ANGIODYNAMICS, INC.
    Inventors: Peter Callas, David Warden, Robert M. Pearson
  • Publication number: 20240074804
    Abstract: The present invention relates to medical devices and methods for treating a lesion such as a vascular stenosis using non-thermal irreversible electroporation (NTIRE). Embodiments of the present invention provide a balloon catheter type NTIRE device for treating a target lesion comprising a plurality of electrodes positioned along the balloon that are electrically independent from each other so as to be individually selectable in order to more precisely treat an asymmetrical lesion in which the lesion extends only partially around the vessel.
    Type: Application
    Filed: November 6, 2023
    Publication date: March 7, 2024
    Inventors: Robert E. Neal, Paulo A. Garcia, Rafael V. Davalos, Peter Callas
  • Publication number: 20230414124
    Abstract: An implantable sensor for implantation in a vessel, comprising a plurality of electrodes for placement on, in or adjacent a vessel wall, means for providing a drive signal to the electrodes, means for measuring at least one of impedance and capacitance between at least two of the plurality of electrodes, and means for wirelessly communicating data from the sensor and a blood vessel monitoring system comprising same.
    Type: Application
    Filed: September 12, 2023
    Publication date: December 28, 2023
    Inventors: Fiachra M. Sweeney, Hanson S. Gifford, III, Douglas S. Sutton, Brian Wilfley, Edward McKenna, Xuance Zhou, Peter Callas, Danyang Fan
  • Publication number: 20230330421
    Abstract: A system for synchronizing application of treatment signals with a cardiac rhythm is provided. The system includes a memory that receives and stores a synchronization signal indicating that a predetermined phase such as R-wave of a cardiac rhythm of a patient has started.
    Type: Application
    Filed: June 23, 2023
    Publication date: October 19, 2023
    Applicant: AngioDynamics, Inc.
    Inventors: Peter CALLAS, James LOVEWELL, Bradley C. STRIBLING, Dave WARDEN
  • Patent number: 11779238
    Abstract: An implantable sensor for implantation in a vessel, comprising a plurality of electrodes for placement on, in or adjacent a vessel wall, means for providing a drive signal to the electrodes, means for measuring at least one of impedance and capacitance between at least two of the plurality of electrodes, and means for wirelessly communicating data from the sensor and a blood vessel monitoring system comprising same.
    Type: Grant
    Filed: May 31, 2018
    Date of Patent: October 10, 2023
    Assignee: Foundry Innovation & Research 1, Ltd.
    Inventors: Fiachra M. Sweeney, Hanson S. Gifford, III, Douglas S. Sutton, Brian Wilfley, Edward McKenna, Xuance Zhou, Peter Callas, Danyang Fan
  • Patent number: 11707629
    Abstract: A system for synchronizing application of treatment signals with a cardiac rhythm is provided. The system includes a memory that receives and stores a synchronization signal indicating that a predetermined phase such as R-wave of a cardiac rhythm of a patient has started. A synchronization module analyzes whether the stored synchronization signal is erroneous and if so, prevents a medical treatment device from applying a treatment energy signal such as an IRE pulse to a patient to take into account an irregular heart beat and noise in the synchronization signal in order to maximize safety of the patient.
    Type: Grant
    Filed: November 23, 2020
    Date of Patent: July 25, 2023
    Assignee: AngioDynamics, Inc.
    Inventors: Peter Callas, James Lovewell, Bradley C. Stribling, Dave Warden
  • Publication number: 20210369325
    Abstract: System for electrically ablating tissue of a patient through a plurality of electrodes includes a memory, a processor and a treatment control module stored in the memory and executable by the processor. The treatment control module generates an estimated treatment region based on the number of electrical pulses to be applied.
    Type: Application
    Filed: June 14, 2021
    Publication date: December 2, 2021
    Applicant: ANGIODYNAMICS, INC.
    Inventors: Peter Callas, David Warden, Robert M. Pearson
  • Patent number: 11033324
    Abstract: System for electrically ablating tissue of a patient through a plurality of electrodes includes a memory, a processor and a treatment control module stored in the memory and executable by the processor. The treatment control module generates an estimated treatment region based on the number of electrical pulses to be applied.
    Type: Grant
    Filed: December 17, 2018
    Date of Patent: June 15, 2021
    Assignee: AngioDynamics, Inc.
    Inventors: Peter Callas, David Warden, Robert M. Pearson
  • Publication number: 20210093870
    Abstract: A system for synchronizing application of treatment signals with a cardiac rhythm is provided. The system includes a memory that receives and stores a synchronization signal indicating that a predetermined phase such as R-wave of a cardiac rhythm of a patient has started. A synchronization module analyzes whether the stored synchronization signal is erroneous and if so, prevents a medical treatment device from applying a treatment energy signal such as an IRE pulse to a patient to take into account an irregular heart beat and noise in the synchronization signal in order to maximize safety of the patient.
    Type: Application
    Filed: November 23, 2020
    Publication date: April 1, 2021
    Applicant: AngioDynamics, Inc.
    Inventors: Peter Callas, James Lovewell, Bradley C. Stribling, Dave Warden
  • Publication number: 20210030470
    Abstract: A method for treating Chronic Obstructive Pulmonary Disease (COPD) or chronic bronchitis to alleviate the discomforts of breathing by using non-thermal electroporation energy to ablate diseased portions of the lung including the bronchus, airways and alveoli which, in effect, opens the restrictive diseased portions thereby maximizing the overall surface area thereof causing improved airflow and uninhibited breathing.
    Type: Application
    Filed: October 20, 2020
    Publication date: February 4, 2021
    Applicant: AngioDynamics, Inc.
    Inventors: Robert Pearson, Mark Ortiz, Peter Callas
  • Patent number: 10813688
    Abstract: A method for treating Chronic Obstructive Pulmonary Disease (COPD) or chronic bronchitis to alleviate the discomforts of breathing by using non-thermal electroporation energy to ablate diseased portions of the lung including the bronchus, airways and alveoli which, in effect, opens the restrictive diseased portions thereby maximizing the overall surface area thereof causing improved airflow and uninhibited breathing.
    Type: Grant
    Filed: November 23, 2015
    Date of Patent: October 27, 2020
    Assignee: AngioDynamics, Inc.
    Inventors: Robert Pearson, Mark Ortiz, Peter Callas
  • Publication number: 20200323576
    Abstract: The present invention relates to medical devices and methods for treating a lesion such as a vascular stenosis using non-thermal irreversible electroporation (NTIRE). Embodiments of the present invention provide a balloon catheter type NTIRE device for treating a target lesion comprising a plurality of electrodes positioned along the balloon that are electrically independent from each other so as to be individually selectable in order to more precisely treat an asymmetrical lesion in which the lesion extends only partially around the vessel.
    Type: Application
    Filed: May 4, 2020
    Publication date: October 15, 2020
    Inventors: Robert E. Neal, Paulo A. Garcia, Rafael V. Davalos, Peter Callas
  • Patent number: 10702326
    Abstract: The present invention relates to medical devices and methods for treating a lesion such as a vascular stenosis using non-thermal irreversible electroporation (NTIRE). Embodiments of the present invention provide a balloon catheter type NTIRE device for treating a target lesion comprising a plurality of electrodes positioned along the balloon that are electrically independent from each other so as to be individually selectable in order to more precisely treat an asymmetrical lesion in which the lesion extends only partially around the vessel.
    Type: Grant
    Filed: July 16, 2012
    Date of Patent: July 7, 2020
    Assignees: Virginia Tech Intellectual Properties, Inc., AngioDynamics, Inc.
    Inventors: Robert E. Neal, II, Paulo A. Garcia, Rafael V. Davalos, Peter Callas
  • Publication number: 20200129087
    Abstract: An implantable sensor for implantation in a vessel, comprising a plurality of electrodes for placement on, in or adjacent a vessel wall, means for providing a drive signal to the electrodes, means for measuring at least one of impedance and capacitance between at least two of the plurality of electrodes, and means for wirelessly communicating data from the sensor and a blood vessel monitoring system comprising same.
    Type: Application
    Filed: May 31, 2018
    Publication date: April 30, 2020
    Inventors: Fiachra M. Sweeney, Hanson S. Gifford, III, Douglas S. Sutton, Brian Wilfley, Edward McKenna, Xuance Zhou, Peter Callas, Danyang Fan
  • Publication number: 20190328446
    Abstract: System for increasing a target zone for electrical ablation includes a treatment control module executable by a processor. The control module directs a pulse generator to apply pre-conditioning pulses to subject tissue cells in a pre-conditioning zone to electroporation, the pre-conditioning zone being smaller than a target ablation zone. After the pre-conditioning pulses have been applied, the control module directs the pulse generator to apply treatment pulses to electrically ablate the tissue cells in the target ablation zone. The pre-conditioning pulses cause the pre-conditioning zone to have a much higher conductivity so that the zone acts as a larger electrode area when the treatment pulses are applied, which results in a much larger target ablation zone than otherwise possible.
    Type: Application
    Filed: July 8, 2019
    Publication date: October 31, 2019
    Applicant: AngioDynamics, Inc.
    Inventors: Peter Callas, Wesley Chung Joe
  • Patent number: 10342600
    Abstract: System for increasing a target zone for electrical ablation includes a treatment control module executable by a processor. The control module directs a pulse generator to apply pre-conditioning pulses to subject tissue cells in a pre-conditioning zone to electroporation, the pre-conditioning zone being smaller than a target ablation zone. After the pre-conditioning pulses have been applied, the control module directs the pulse generator to apply treatment pulses to electrically ablate the tissue cells in the target ablation zone. The pre-conditioning pulses cause the pre-conditioning zone to have a much higher conductivity so that the zone acts as a larger electrode area when the treatment pulses are applied, which result in a much larger target ablation zone than otherwise possible.
    Type: Grant
    Filed: April 28, 2016
    Date of Patent: July 9, 2019
    Inventors: Peter Callas, Wesley Chung Joe
  • Publication number: 20190159829
    Abstract: System for electrically ablating tissue of a patient through a plurality of electrodes includes a memory, a processor and a treatment control module stored in the memory and executable by the processor. The treatment control module generates an estimated treatment region based on the number of electrical pulses to be applied.
    Type: Application
    Filed: December 17, 2018
    Publication date: May 30, 2019
    Applicant: AngioDynamics, Inc.
    Inventors: Peter Callas, David Warden, Robert M. Pearson
  • Publication number: 20190030343
    Abstract: A system for synchronizing application of treatment signals with a cardiac rhythm is provided. The system includes a memory that receives and stores a synchronization signal indicating that a predetermined phase such as R-wave of a cardiac rhythm of a patient has started. A synchronization module analyzes whether the stored synchronization signal is erroneous and if so, prevents a medical treatment device from applying a treatment energy signal such as an IRE pulse to a patient to take into account an irregular heart beat and noise in the synchronization signal in order to maximize safety of the patient.
    Type: Application
    Filed: October 1, 2018
    Publication date: January 31, 2019
    Applicant: AngioDynamics, Inc.
    Inventors: Peter Callas, James Lovewell, Bradley C. Stribling, Dave Warden
  • Patent number: 10154876
    Abstract: System for electrically ablating tissue of a patient through a plurality of electrodes includes a memory, a processor and a treatment control module stored in the memory and executable by the processor. The treatment control module generates an estimated treatment region based on the number of electrical pulses to be applied.
    Type: Grant
    Filed: June 2, 2017
    Date of Patent: December 18, 2018
    Assignee: AngioDynamics, Inc.
    Inventors: Peter Callas, David Warden, Robert M. Pearson
  • Patent number: 10130819
    Abstract: A system for synchronizing application of treatment signals with a cardiac rhythm is provided. The system includes a memory that receives and stores a synchronization signal indicating that a predetermined phase such as R-wave of a cardiac rhythm of a patient has started. A synchronization module analyzes whether the stored synchronization signal is erroneous and if so, prevents a medical treatment device from applying a treatment energy signal such as an IRE pulse to a patient to take into account an irregular heart beat and noise in the synchronization signal in order to maximize safety of the patient.
    Type: Grant
    Filed: August 18, 2017
    Date of Patent: November 20, 2018
    Assignee: AngioDynamics, Inc.
    Inventors: Peter Callas, James Lovewell, Bradley C. Stribling, Dave Warden